<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id>
      <journal-title-group>
        <journal-title>BMC Research Notes</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-0500</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26578339</article-id>
      <article-id pub-id-type="pmc">4650112</article-id>
      <article-id pub-id-type="publisher-id">1610</article-id>
      <article-id pub-id-type="doi">10.1186/s13104-015-1610-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Long term follow-up of persistent choroidal folds and hyperopic shift after complete removal of a retrobulbar mass</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jacobsen</surname>
            <given-names>Agnes Galbo</given-names>
          </name>
          <address>
            <email>agnes.jacobsen@rn.dk</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Toft</surname>
            <given-names>Peter Bjerre</given-names>
          </name>
          <address>
            <email>Peter.Bjerre.Toft@regionh.dk</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Prause</surname>
            <given-names>Jan Ulrik</given-names>
          </name>
          <address>
            <email>jup@sund.ku.dk</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vorum</surname>
            <given-names>Henrik</given-names>
          </name>
          <address>
            <email>henrik.vorum@rn.dk</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Hargitai</surname>
            <given-names>J&#xE1;nos</given-names>
          </name>
          <address>
            <email>janos.hargitai@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark </aff>
        <aff id="Aff2"><label/>Eye Clinic, Rigshospitalet and Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark </aff>
        <aff id="Aff3"><label/>Eye Pathology Institute, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark </aff>
        <aff id="Aff4"><label/>Department of Ophthalmology, Thy-Mors Hospital, Thisted, Denmark </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>14</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>678</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Jacobsen et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Hyperopic shift and chorioretinal folds are common findings with intraorbital masses compressing the posterior pole of the globe. These signs usually regress after complete tumour excision. To the best of our knowledge this is the first reported case, where optical coherence tomography was used to document persistent chorioretinal folds after complete excision of a retrobulbar mass.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 47-year-old Caucasian woman was referred to our department with long-documented hyperopic shift and gradually decreasing vision in her left eye. Optical coherence tomography showed chorioretinal folds. Magnetic resonance imaging revealed a retrobulbar mass which caused flattening of the posterior pole of the globe. The tumour was successfully removed, and was confirmed to be a cavernous haemangioma on histological assessment. 3&#xA0;years after surgery the patient still has a similar amount of hyperopia and chorioretinal folds.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Choroidal folds and hyperopic shift may persist after complete tumour removal. Long term follow-up is advised to rule out recurrence of the intraorbital mass.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Choroidal fold</kwd>
        <kwd>Hyperopic shift</kwd>
        <kwd>Intraorbital mass</kwd>
        <kwd>Cavernous haemangioma</kwd>
        <kwd>Optical coherence tomography</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Cavernous haemangioma is the most common benign orbital neoplasm in adults [<xref ref-type="bibr" rid="CR1">1</xref>]. Cavernous haemangiomas and other orbital tumours may compress the globe and induce choroidal folds and refractive changes. Choroidal folds are parallel grooves or striae involving the inner choroid, the Bruch&#x2019;s membrane and the retinal pigment epithelium (RPE), and sometimes the retina (chorioretinal folds) [<xref ref-type="bibr" rid="CR2">2</xref>]. Optical coherence tomography (OCT) provides cross-sectional images of the retina and choroid, making it useful for investigation of choroidal folds [<xref ref-type="bibr" rid="CR3">3</xref>]. Symptoms from choroidal folds can vary depending on their cause and the rapidity of their progression. If the folds occur acutely, they can produce metamorphopsia caused by distortion of photoreceptors, but if they develop slowly vision can be preserved [<xref ref-type="bibr" rid="CR3">3</xref>]. Hyperopic shift is a common finding if a mass compresses the posterior pole. Acquired chorioretinal folds and hyperopia usually regress after successful tumour removal [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. We report a case with persistent hyperopia and chorioretinal folds 3&#xA0;years after successful tumour removal.</p>
    </sec>
    <sec id="Sec2">
      <title>Case report</title>
      <p>A 47-year-old Caucasian woman was referred to our department because of visual loss and left papillary oedema. She had originally contacted her ophthalmologist for heavy eyelids and a wish for upper blepharoplasty.</p>
      <p>The patient history revealed fluctuating vision in the left eye for the previous 5&#xA0;years and intermittent tinnitus in the left ear. The fluctuating vision was confirmed in notes obtained from her optometrist (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Apart from a hemithyroidectomy due to a &#x201C;cold notch&#x201D;, her past medical history was uneventful.<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Refraction and best-corrected visual acuity</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Date</th><th align="left">Ref. RE</th><th align="left">BCVA RE</th><th align="left">Ref. LE</th><th align="left">BCVA LE</th></tr></thead><tbody><tr><td align="left">12/1999</td><td char="+" align="char">+1.25D/&#x2212;0.75&#xA0;&#xD7;&#xA0;180</td><td align="left">6/6</td><td char="+" align="char">+1.0D/&#x2212;0.5&#xA0;&#xD7;&#xA0;180</td><td align="left">6/6</td></tr><tr><td align="left">8/2007</td><td char="+" align="char">+2.5D/&#x2212;0.5&#xA0;&#xD7;&#xA0;5</td><td align="left">6/6</td><td char="+" align="char">+4.0D/&#x2212;0.5&#xA0;&#xD7;&#xA0;180</td><td align="left">6/7.5</td></tr><tr><td align="left">12/2009</td><td char="+" align="char">+2.75D/&#x2212;0.25&#xA0;&#xD7;&#xA0;5</td><td align="left">6/6</td><td char="+" align="char">+5.75D/&#x2212;0.25&#xA0;&#xD7;&#xA0;180</td><td align="left">6/10</td></tr><tr><td align="left">03/2010</td><td char="+" align="char">+2.75D/&#x2212;1.0&#xA0;&#xD7;&#xA0;10</td><td align="left">6/6</td><td char="+" align="char">+5.5D/&#x2212;0.5&#xA0;&#xD7;&#xA0;5</td><td align="left">6/7.5</td></tr><tr><td align="left">11/2010</td><td char="+" align="char">+2.75D/&#x2212;0.75 5</td><td align="left">6/6</td><td char="+" align="char">+5.75D/&#x2212;0.5&#xA0;&#xD7;&#xA0;5</td><td align="left">6/6</td></tr><tr><td align="left">
<italic>11/2011</italic>
</td><td char="+" align="char">
<italic>+2.5D/&#x2212;0.5</italic>&#xA0;<italic>&#xD7;</italic>&#xA0;<italic>20</italic>
</td><td align="left">
<italic>6/6</italic>
</td><td char="+" align="char">
<italic>+6.5D/&#x2212;1.25</italic>&#xA0;<italic>&#xD7;</italic>&#xA0;<italic>0</italic>
</td><td align="left">
<italic>6/12</italic>
</td></tr><tr><td align="left">10/2012</td><td char="+" align="char">+2.5D/&#x2212;0.5&#xA0;&#xD7;&#xA0;15</td><td align="left">6/6</td><td char="+" align="char">+6.0D/&#x2212;1.25&#xA0;&#xD7;&#xA0;0</td><td align="left">6/9</td></tr><tr><td align="left">09/2013</td><td char="+" align="char">+2.5D/&#x2212;0.5&#xA0;&#xD7;&#xA0;15</td><td align="left">6/6</td><td char="+" align="char">+6.0D/&#x2212;1.25&#xA0;&#xD7;&#xA0;0</td><td align="left">6/9</td></tr><tr><td align="left">10/2014</td><td char="+" align="char">+2.5D/&#x2212;0.5&#xA0;&#xD7;&#xA0;15</td><td align="left">6/6</td><td char="+" align="char">+6.0D/&#x2212;1.25&#xA0;&#xD7;&#xA0;0</td><td align="left">6/8</td></tr></tbody></table><table-wrap-foot><p>A 15-year-long follow-up of the patient&#x2019;s refraction and best-corrected visual acuity</p><p>Time of presentation (1&#xA0;week prior to tumour removal) is highlighted in italics</p><p>
<italic>Ref</italic> refraction, <italic>BCVA</italic> best-corrected visual acuity, <italic>RE</italic> right eye, <italic>LE</italic> left eye, <italic>D</italic> diopter</p></table-wrap-foot></table-wrap></p>
      <p>Refraction was +2.5D (diopter)/&#x2212;0.5D&#xA0;&#xD7;&#xA0;20 in the right eye and +6.5D/&#x2212;1.25D X 0 in the left eye. Best-corrected visual acuity (BCVA) was 6/6 in the right and 6/12 in left eye.</p>
      <p>The patient had 3&#xA0;mm left axial proptosis measured with Hertel exophthalmometer. Full extraocular movements and no afferent pupillary defects were found. Funduscopy revealed horizontal chorioretinal folds and mild papilloedema. These findings were documented with spectral-domain optical coherence tomography (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a).<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Optical coherence tomography imaging of the macula. Spectral-domain optical coherence tomography imaging showing chorioretinal folds of the left macula at presentation (<bold>a</bold>); unchanged folds 3&#xA0;years after complete tumour removal (<bold>b</bold>)</p></caption><graphic xlink:href="13104_2015_1610_Fig1_HTML" id="MO1"/></fig></p>
      <p>Magnetic resonance imaging (MRI) showed a well-circumscribed, homogenous, 18&#xA0;&#xD7;&#xA0;13.6&#xA0;mm large, oval-shaped intraconal mass between the lateral rectus muscle and the optic nerve in the left orbit (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>a). A pronounced flattening of the posterior pole of the left globe was documented. Axial length (AXL) was 22.20&#xA0;mm in the right eye and 20.80&#xA0;mm in the left eye.<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Magnetic resonance imaging of the orbit. Magnetic resonance imaging (T2), axial view showing the patient at presentation (<bold>a</bold>) with intraconal mass in the left orbit (<italic>green arrow</italic>), and flattening of the posterior pole (<italic>red arrow</italic>); 3&#xA0;years after complete removal of the tumour, posterior pole flattening (<italic>red arrow</italic>) persisted (<bold>b</bold>)</p></caption><graphic xlink:href="13104_2015_1610_Fig2_HTML" id="MO2"/></fig></p>
      <p>The patient was admitted to the university department where the tumour was removed through anterior orbitotomy. Histopathology confirmed a cavernous haemangioma of the orbit (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). The patient made an uncomplicated recovery. She was followed every half year for 3&#xA0;years after surgery. At the third-year control visit BCVA had improved to 6/8, and the refraction had stabilized at +6.0D/&#x2212;0.75D X 175 in the left eye. Control OCT examination showed unchanged chorioretinal folds (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b). Follow-up MRI showed no signs of recurrence, but the posterior flattening of the left globe remained unchanged (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>b). Control assessment found that AXL was 22.20&#xA0;mm in right eye and 20.81&#xA0;mm in the left eye.<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Histological examination. Histopathology of the excised tumour showing characteristic closely-spaced, thin-walled vessels. Hematoxylin and eosin staining</p></caption><graphic xlink:href="13104_2015_1610_Fig3_HTML" id="MO3"/></fig></p>
    </sec>
    <sec id="Sec3" sec-type="conclusion">
      <title>Conclusion</title>
      <p>Several reports have confirmed that choroidal folds tend to regress after removal of an orbital mass [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. However, in a few cases the folds persist for several years postoperatively [<xref ref-type="bibr" rid="CR6">6</xref>]. The persistent flattening of the posterior pole and choroidal folds has been attributed to scleral remodelling after long-standing compression [<xref ref-type="bibr" rid="CR6">6</xref>]. The presence of persisting flat posterior pole, chorioretinal folds, and hyperopia in our case may also be explained by this. Cavernous haemangiomas have a slow growth pattern; many patients have manifestation of tumour growth for more than 10&#xA0;years without developing uncorrectable visual loss [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Our patient had presumably developed the orbital mass several years before its diagnosis, which is supported by the longstanding visual symptoms; thus, an irreversible structural change of the sclera could have occurred. To the best our knowledge, this is the first reported case to show persistent chorioretinal folds and globe flattening after removal of a cavernous haemangioma of the orbit, confirmed by OCT and MRI.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>BCVA</term>
          <def>
            <p>best-corrected visual acuity</p>
          </def>
        </def-item>
        <def-item>
          <term>D</term>
          <def>
            <p>diopter</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>OCT</term>
          <def>
            <p>optical coherence tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>RPE</term>
          <def>
            <p>retinal pigment epithelium</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <title>Authors&#x2019; contributions</title>
      <p>AGS have drafted the manuscript, and performed clinical assessment; PBT have performed surgical intervention; JUP have performed histopathological assessment and helped in drafting the manuscript; HV helped drafting the manuscript, and performed language correction; JH have drafted the manuscript, and performed OCT examinations. All authors read and approved the final version of the manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>None.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar3">
        <title>Informed consent</title>
        <p>Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Garrity</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Cameron</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Garrity</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Cameron</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Vascular hamartomas, hyperplasia and neoplasms</article-title>
          <source>Henderson&#xB4;s orbital tumors</source>
          <year>2007</year>
          <publisher-loc>Baltimore</publisher-loc>
          <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
          <fpage>192</fpage>
          <lpage>197</lpage>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kanski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bowling</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Kanski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bowling</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Acquired Macular Disorders</article-title>
          <source>Clinical ophthalmology-a systemic approach</source>
          <year>2011</year>
          <publisher-loc>Edinburgh</publisher-loc>
          <publisher-name>Elsevier Saunders</publisher-name>
          <fpage>643</fpage>
          <lpage>644</lpage>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giuffr&#xE8;</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Distefano</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Optical coherence tomography of chorioretinal and choroidal folds</article-title>
          <source>Acta Ophthalmol Scand</source>
          <year>2007</year>
          <volume>85</volume>
          <fpage>333</fpage>
          <lpage>336</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0420.2006.00799.x</pub-id>
          <pub-id pub-id-type="pmid">17488465</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kroll</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Norton</surname>
              <given-names>EW</given-names>
            </name>
          </person-group>
          <article-title>Regression of choroidal folds</article-title>
          <source>Trans Am Acad Ophthalmol Otolaryngol.</source>
          <year>1970</year>
          <volume>74</volume>
          <fpage>515</fpage>
          <lpage>526</lpage>
          <pub-id pub-id-type="pmid">5425204</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zubilewicz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dolar-Szczasny</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rakowska</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mackiewicz</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Optical coherence tomography in monitoring of choroidal folds after surgical excision of ethmoidal myxoma</article-title>
          <source>Klin Oczna</source>
          <year>2013</year>
          <volume>115</volume>
          <fpage>141</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="pmid">24059031</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Leibovitch</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Selva</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Persistent posterior globe flattening after orbital cavernous haemangioma excision</article-title>
          <source>Clin Experiment Ophthalmol</source>
          <year>2005</year>
          <volume>33</volume>
          <fpage>424</fpage>
          <lpage>425</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1442-9071.2005.01016.x</pub-id>
          <pub-id pub-id-type="pmid">16033365</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leatherbarrow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Noble</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Lloyd</surname>
              <given-names>IC</given-names>
            </name>
          </person-group>
          <article-title>Cavernous haemangioma of the orbit</article-title>
          <source>Eye</source>
          <year>1989</year>
          <volume>3</volume>
          <fpage>90</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="doi">10.1038/eye.1989.13</pub-id>
          <pub-id pub-id-type="pmid">2687041</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simpson</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Alford</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Permanent axial length change as a result of cavernous hemangioma</article-title>
          <source>Optom Vis Sci</source>
          <year>2011</year>
          <volume>88</volume>
          <fpage>890</fpage>
          <lpage>893</lpage>
          <pub-id pub-id-type="doi">10.1097/OPX.0b013e318219d278</pub-id>
          <pub-id pub-id-type="pmid">21516049</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
